Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Pulmonary Manifestations and Progression of Lung Disease in Juvenile-onset Mixed Connective Tissue Disease.

Hetlevik SO, Flatø B, Aaløkken TM, Lund MB, Reiseter S, Mynarek GK, Nordal E, Rygg M, Lilleby V.

J Rheumatol. 2019 Jan;46(1):93-100. doi: 10.3899/jrheum.180019. Epub 2018 Aug 1.

PMID:
30068767
2.

Chest abnormalities in juvenile-onset mixed connective tissue disease: assessment with high-resolution computed tomography and pulmonary function tests.

Aaløkken TM, Lilleby V, Søyseth V, Mynarek G, Pripp AH, Johansen B, Førre O, Kolbenstvedt A.

Acta Radiol. 2009 May;50(4):430-6. doi: 10.1080/02841850902787677.

PMID:
19277918
3.

Pulmonary involvement in long-term mixed connective tissue disease: functional trends and image findings after 10 years.

Kawano-Dourado L, Baldi BG, Kay FU, Dias OM, Gripp TE, Gomes PS, Fuller R, Caleiro MT, Kairalla RA, Carvalho CR.

Clin Exp Rheumatol. 2015 Mar-Apr;33(2):234-40. Epub 2015 Apr 10.

PMID:
25896472
4.

Pulmonary Involvement in the Antisynthetase Syndrome: A Comparative Cross-sectional Study.

Andersson H, Aaløkken TM, Günther A, Mynarek GK, Garen T, Lund MB, Molberg Ø.

J Rheumatol. 2016 Jun;43(6):1107-13. doi: 10.3899/jrheum.151067. Epub 2016 Apr 1.

PMID:
27036381
5.

Performance of Forced Vital Capacity and Lung Diffusion Cutpoints for Associated Radiographic Interstitial Lung Disease in Systemic Sclerosis.

Showalter K, Hoffmann A, Rouleau G, Aaby D, Lee J, Richardson C, Dematte J, Agrawal R, Chang RW, Hinchcliff M.

J Rheumatol. 2018 Nov;45(11):1572-1576. doi: 10.3899/jrheum.171362. Epub 2018 Oct 1.

PMID:
30275265
6.

Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD).

Bodolay E, Szekanecz Z, Dévényi K, Galuska L, Csípo I, Vègh J, Garai I, Szegedi G.

Rheumatology (Oxford). 2005 May;44(5):656-61. Epub 2005 Feb 16.

PMID:
15716315
7.

Prevalence and severity of interstitial lung disease in mixed connective tissue disease: a nationwide, cross-sectional study.

Gunnarsson R, Aaløkken TM, Molberg Ø, Lund MB, Mynarek GK, Lexberg AS, Time K, Dhainaut AS, Bertelsen LT, Palm O, Irgens K, Becker-Merok A, Nordeide JL, Johnsen V, Pedersen S, Prøven A, Garabet LS, Gran JT.

Ann Rheum Dis. 2012 Dec;71(12):1966-72. doi: 10.1136/annrheumdis-2011-201253. Epub 2012 May 1.

PMID:
22550317
8.

Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease.

Le Gouellec N, Duhamel A, Perez T, Hachulla AL, Sobanski V, Faivre JB, Morell-Dubois S, Lambert M, Hatron PY, Hachulla E, Béhal H, Matran R, Launay D, Remy-Jardin M.

PLoS One. 2017 Aug 1;12(8):e0181692. doi: 10.1371/journal.pone.0181692. eCollection 2017.

9.

Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease.

Suliman YA, Dobrota R, Huscher D, Nguyen-Kim TD, Maurer B, Jordan S, Speich R, Frauenfelder T, Distler O.

Arthritis Rheumatol. 2015 Dec;67(12):3256-61. doi: 10.1002/art.39405.

10.

Pulmonary outcome in juvenile dermatomyositis: a case-control study.

Sanner H, Aaløkken TM, Gran JT, Sjaastad I, Johansen B, Flatø B.

Ann Rheum Dis. 2011 Jan;70(1):86-91. doi: 10.1136/ard.2010.131433. Epub 2010 Aug 30.

PMID:
20805295
11.

Serum KL-6 and surfactant protein-D as monitoring and predictive markers of interstitial lung disease in patients with systemic sclerosis and mixed connective tissue disease.

Yamakawa H, Hagiwara E, Kitamura H, Yamanaka Y, Ikeda S, Sekine A, Baba T, Okudela K, Iwasawa T, Takemura T, Kuwano K, Ogura T.

J Thorac Dis. 2017 Feb;9(2):362-371. doi: 10.21037/jtd.2017.02.48.

12.

Rituximab in connective tissue disease-associated interstitial lung disease.

Duarte AC, Cordeiro A, Fernandes BM, Bernardes M, Martins P, Cordeiro I, Santiago T, Seixas MI, Ribeiro AR, Santos MJ.

Clin Rheumatol. 2019 Jul;38(7):2001-2009. doi: 10.1007/s10067-019-04557-7. Epub 2019 Apr 23.

PMID:
31016581
13.

Cyclosporine in anti-Jo1-positive patients with corticosteroid-refractory interstitial lung disease.

Cavagna L, Caporali R, Abdì-Alì L, Dore R, Meloni F, Montecucco C.

J Rheumatol. 2013 Apr;40(4):484-92. doi: 10.3899/jrheum.121026. Epub 2013 Feb 15.

PMID:
23418387
14.

Association of gastroesophageal factors and worsening of forced vital capacity in systemic sclerosis.

Zhang XJ, Bonner A, Hudson M; Canadian Scleroderma Research Group, Baron M, Pope J.

J Rheumatol. 2013 Jun;40(6):850-8. doi: 10.3899/jrheum.120705. Epub 2013 Apr 1.

PMID:
23547215
15.

Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parameters.

Fischer A, Swigris JJ, Bolster MB, Chung L, Csuka ME, Domsic R, Frech T, Hinchcliff M, Hsu V, Hummers LK, Gomberg-Maitland M, Mathai SC, Simms R, Steen VD.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-109-14. Epub 2014 Nov 4.

PMID:
25372796
16.

Asymptomatic preclinical rheumatoid arthritis-associated interstitial lung disease.

Chen J, Shi Y, Wang X, Huang H, Ascherman D.

Clin Dev Immunol. 2013;2013:406927. doi: 10.1155/2013/406927. Epub 2013 Jul 31.

17.

Interstitial lung disease in systemic sclerosis.

Ooi GC, Mok MY, Tsang KW, Wong Y, Khong PL, Fung PC, Chan S, Tse HF, Wong RW, Lam WK, Lau CS.

Acta Radiol. 2003 May;44(3):258-64.

PMID:
12751995
18.

Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease.

Caron M, Hoa S, Hudson M, Schwartzman K, Steele R.

Eur Respir Rev. 2018 May 15;27(148). pii: 170102. doi: 10.1183/16000617.0102-2017. Print 2018 Jun 30. Review.

19.

Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.

Collins BF, Spiekerman CF, Shaw MA, Ho LA, Hayes J, Spada CA, Stamato CM, Raghu G.

Chest. 2017 Jul;152(1):103-112. doi: 10.1016/j.chest.2017.03.004. Epub 2017 Mar 12.

20.

Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study.

Kelly CA, Saravanan V, Nisar M, Arthanari S, Woodhead FA, Price-Forbes AN, Dawson J, Sathi N, Ahmad Y, Koduri G, Young A; British Rheumatoid Interstitial Lung (BRILL) Network.

Rheumatology (Oxford). 2014 Sep;53(9):1676-82. doi: 10.1093/rheumatology/keu165. Epub 2014 Apr 23.

PMID:
24758887

Supplemental Content

Support Center